Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
384,509,293
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
133,583,585
-
Shares change
-
+133,572,485
-
Total reported value, excl. options
-
$2,019,181,000
-
Value change
-
+$2,019,011,980
-
Number of buys
-
74
-
Price
-
$15.27
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q4 2018
75 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q4 2018.
Moderna, Inc. - COMMON STOCK (MRNA) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 133,583,585 shares
of 384,509,293 outstanding shares and own 35% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (58,807,379 shares), Viking Global Investors LP (17,081,164 shares), FMR LLC (15,276,445 shares), Artal Group S.A. (5,256,298 shares), BB BIOTECH AG (4,785,681 shares), FIDUCIARY TRUST CO (4,311,927 shares), WELLINGTON MANAGEMENT GROUP LLP (3,052,831 shares), MORGAN STANLEY (2,153,120 shares), BAILLIE GIFFORD & CO (1,725,844 shares), and CANADA PENSION PLAN INVESTMENT BOARD (1,600,000 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.